Table 3. The pooled results of subgroups for the association between Cyclin B1 and 3-year OS or 5-year OS.
| Subgroups | Number of studies | Pooled results (3-year OS) | Pooled results (5-year OS) | ||||
|---|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | ||
| Clinical stage | |||||||
| I–IV | 7 | 0.93 | 0.40, 2.17 | 0.86 | 0.77 | 0.32, 1.88 | 0.56 |
| I–III | 2 | 0.25 | 0.11, 0.58 | 0.001 | 0.23 | 0.11, 0.48 | < 0.0001 |
| P value of TNM stage | |||||||
| < 0.05 | 4 | 0.34 | 0.05, 2.30 | 0.27 | 0.32 | 0.13, 0.76 | 0.010 |
| > 0.05 | 4 | 0.59 | 0.24, 1.46 | 0.25 | 0.49 | 0.13, 1.91 | 0.30 |
| Cut-off value | |||||||
| 10% | 5 | 0.87 | 0.31, 2.41 | 0.78 | 0.59 | 0.31, 1.12 | 0.11 |
| ≤ 5% | 4 | 1.25 | 0.35, 4.51 | 0.73 | 1.43 | 0.20, 10.38 | 0.72 |
OS, overall survival; OR, odds ratio; CI, confidence intervals.